IsoPlexis to Report Second Quarter 2022 Financial Results on August 10, 2022
July 21, 2022 07:00 ET
|
IsoPlexis Corporation
BRANFORD, Conn., July 21, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), the Superhuman Cell Company, today announced it will report financial results for the second quarter 2022...
IsoPlexis Reports First Quarter 2022 Financial Results
May 11, 2022 07:00 ET
|
IsoPlexis Corporation
BRANFORD, Conn., May 11, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), the Superhuman Cell Company, today reported financial results for the quarter ended March 31, 2022. Recent...
IsoPlexis Reports Preliminary First Quarter 2022 Revenue, Streamlines Operating Structure to Support Sustainable Growth
April 11, 2022 16:05 ET
|
IsoPlexis Corporation
BRANFORD, Conn., April 11, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO) (“IsoPlexis”), the Superhuman Cell Company, today announced its preliminary unaudited revenue for the first...
IsoPlexis to Present First-of-Its-Kind Data on Simultaneous Single Cell TCR Profiling and Highly Multiplexed Functional Proteomics at AACR 2022
April 08, 2022 07:00 ET
|
IsoPlexis Corporation
BRANFORD, Conn., April 08, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (NASDAQ: ISO), the Superhuman Cell Company, today announced that data generated using its Duomic™ platform demonstrates the...
IsoPlexis Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Revenue Outlook for 2022
March 02, 2022 07:00 ET
|
IsoPlexis Corporation
BRANFORD, Conn., March 02, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), the Superhuman Cell Company, today reported financial results for the quarter and year ended December 31,...
IsoPlexis to Report Fourth Quarter and Full Year 2021 Financial Results on March 2, 2022
February 16, 2022 07:00 ET
|
IsoPlexis Corporation
BRANFORD, Conn., Feb. 16, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), the Superhuman Cell Company, today announced it will report financial results for the fourth quarter and full...
IsoPlexis to Participate in Three Upcoming Investor Conferences
February 11, 2022 07:00 ET
|
IsoPlexis Corporation
BRANFORD, Conn., Feb. 11, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), the Superhuman Cell Company, today announced the company will be participating in the following investor...
IsoPlexis’ Immune Monitoring Helps Identify Early Factors of Long COVID in Cell Publication
February 10, 2022 07:00 ET
|
IsoPlexis Corporation
BRANFORD, Conn., Feb. 10, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (NASDAQ: ISO), the Superhuman Cell Company, today announced the publication of a study in Cell, led by the Institute for...
IsoPlexis Strengthens International Reach and Leadership with First APAC Office and Jason Ou as President/General Manager, APAC Region
February 02, 2022 07:00 ET
|
IsoPlexis Corporation
BRANFORD, Conn., Feb. 02, 2022 (GLOBE NEWSWIRE) -- IsoPlexis, the Superhuman Cell Company, today announced the opening of its first office in the Asia-Pacific (APAC) region headed by Jason Ou as...
IsoPlexis Reports Preliminary Full Year 2021 Revenue, Releases Industry-First Superhuman Cell Library
January 09, 2022 19:00 ET
|
IsoPlexis Corporation
BRANFORD, Conn., Jan. 09, 2022 (GLOBE NEWSWIRE) -- IsoPlexis (NASDAQ: ISO), the Superhuman Cell Company, today announced its preliminary unaudited revenue for the full year 2021. Total revenue for...